Detection of activated ras oncogenes in human thyroid carcinomas
- PMID: 3283656
Detection of activated ras oncogenes in human thyroid carcinomas
Abstract
Focus formation following DNA transfection of mouse 3T3-Vill cells was used to search for the presence of activated oncogenes in human thyroid tumors. Oncogenes belonging to the ras family were detected in four out of six thyroid carcinomas (Ki-ras in one anaplastic tumor and one follicular moderately differentiated tumor and Ha-ras and N-ras in two papillary tumors). Normal thyroid tissue samples obtained from two patients, one with an anaplastic tumor and one with a benign adenoma, and samples from 4 benign adenomas and from one toxic goiter of a patient with Graves' disease gave negative results. In one case, restriction enzyme analysis demonstrated the presence of a mutation in codon 12 of the activated Ha-ras oncogene. Our data show that all three ras proto-oncogenes can become activated in malignant thyroid tumors.
Similar articles
-
Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.Ann Biol Clin (Paris). 1995;53(10-11):549-55. Ann Biol Clin (Paris). 1995. PMID: 8787281
-
Preferential and novel activation of H-ras in human bladder carcinomas.Oncogene Res. 1988;3(1):77-86. Oncogene Res. 1988. PMID: 3144694
-
Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.Oncogene. 1995 Aug 3;11(3):601-3. Oncogene. 1995. PMID: 7630645
-
Genetic mutations in thyroid carcinoma.Minerva Endocrinol. 2009 Mar;34(1):11-28. Minerva Endocrinol. 2009. PMID: 19209125 Review.
-
Activated oncogenes in human tumors.Anticancer Res. 1989 Sep-Oct;9(5):1331-43. Anticancer Res. 1989. PMID: 2686533 Review.
Cited by
-
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.Oncotarget. 2024 Jan 24;15:36-48. doi: 10.18632/oncotarget.28544. Oncotarget. 2024. PMID: 38275291 Free PMC article.
-
Progress in Thyroid Cancer Genomics: A 40-Year Journey.Thyroid. 2023 Nov;33(11):1271-1286. doi: 10.1089/thy.2023.0045. Epub 2023 Sep 4. Thyroid. 2023. PMID: 37668657 Review.
-
A New Indicator to Differentiate Thyroid Follicular Inclusions in Cervical Lymph Nodes from Patients with Thyroid Cancer.Int J Mol Sci. 2022 Dec 28;24(1):490. doi: 10.3390/ijms24010490. Int J Mol Sci. 2022. PMID: 36613940 Free PMC article.
-
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma.Cancer Cell Int. 2022 Aug 22;22(1):263. doi: 10.1186/s12935-022-02680-1. Cancer Cell Int. 2022. PMID: 35996174 Free PMC article.
-
RET signaling pathway and RET inhibitors in human cancer.Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022. Front Oncol. 2022. PMID: 35957881 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous